High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.8M
$2,831,128
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Sell to Cover
2026-03-02
$158,320x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $158,320x2 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Sell to Cover
2026-03-02
$92,846x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $92,846x2 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
Other
|
2026-03-02 | $325,231x2 | M | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Leonard Keith R
• Director
10b5-1 SellΔOwn -64.0%
2026-03-02
$997,195
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -64.0%
|
2026-03-02 | $997,195 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2026-03-02
$220,943x3
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $220,943x3 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $71,844x2 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
Sell to Cover
2026-03-02
$940,528x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $940,528x2 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Welgus Howard G.
• Director
10b5-1 SellΔOwn -16.7%
2026-03-02
$256,518
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -16.7%
|
2026-03-02 | $256,518 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
10b5-1 Sell
2026-02-27
$92,934
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-02-27 | $92,934 | S | Form 4 |